Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices

  1. Law
  2. CFR 21
  3. Food and Drugs
  4. Food and Drug Administration, Department of Health and Human Services
  5. General
  6. Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices

Checkout our iOS App for a better way to browser and research.

Subpart
A

General Information

Subpart
B

Information To Be Disseminated

Subpart
C

Manufacturer's Submissions, Requests, and Applications

Subpart
D

FDA Action on Submissions, Requests, and Applications

Subpart
E

Corrective Actions and Cessation of Dissemination

Subpart
F

Recordkeeping and Reports